Archives of Medical Research · 2021 · 10 citations · 17 references
MedicineOncologyPharmacologyHematologic OncologyMedical OncologyOncology PharmacotherapyCancer ImmunotherapyDosing Of Immuno-oncology AgentsEssential MedicinesHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyMultiple MyelomaDaratumumab TherapyMulticenter TrialsMultiple Myeloma TherapyMultiple Myeloma TreatmentPrescription Drug Utilization Patterns
17
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Meletios Α. Dimopoulos, Albert Oriol, Hareth Nahi et al. · New England Journal of Medicine · 2016 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +16
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
Thierry Façon, Shaji Kumar, Torben Plesner et al. · New England Journal of Medicine · 2019 · 987 citations · Full text
Medicine, Oncology, Pharmacotherapy +13
Philippe Moreau, Michel Attal, Cyrille Hulin et al. · The Lancet · 2019 · 953 citations · Full text